Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Is the legal profession about to step down from its lofty heights into the nitty gritty of big business? If so, what would Alternative Business Structures mean for marketing the law firm?
On April 27, 2011, the United States Supreme Court issued a decision in that will have significant impacts on the prevalence of class-based claims arising out of contracts with consumers.
A cluster of varied, recent rulings by New York's appellate courts offers diverse lessons to practitioners. Often, the actual gleaning is not new, but a good reminder nonetheless.
Features
The Supreme Court decided less than a handful of product liability cases last term. But those it did decide will have great significance in the areas of personal jurisdiction over foreign manufacturers, and federal preemption of state law.
Features
To prevent job applicants with criminal records from being automatically rejected, cities and states are considering and already adopting so-called "Ban the Box" laws and ordinances.
Features
The same pressure to investigate and disclose fees associated with 401(k) plans is now coming to plan administrators in a different form ' new Department of Labor ("DOL") regulations codified at 29 C.F.R. ' 2550.404a-5.
The need to deal fairly with people while also dealing with profitability in a businesslike way has motivated many firms to document a written set of core values or standards that provide clear, firm-wide expectations regarding individual contributions and mutual accountability.
Features
If law firms are to succeed in the new paradigm, careful consideration should be given to incorporating basic management skills training into each new lawyer's career planning process.
Features
The IRS has modified its position on the tax treatment of cell phone services that employers provide to employees primarily for noncompensatory business reasons.
Merck & Co., Inc. became the latest healthcare company to strike a major settlement with the Justice Department on Nov. 22, agreeing to pay $950 million to resolve criminal and civil charges stemming from its marketing of the painkiller Vioxx.